Analysis of metabolite formation pharmacokinetics after intravenous and oral administration of the parent drug using inverse Laplace transformation

Drug Metabolism and Disposition

Volumn 26, Issue 6, 1998, Pages 562-565

  Weiss, Michael ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; DRUG METABOLITE;

ARTICLE; COMPARTMENT MODEL; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG METABOLISM; DRUG TRANSFORMATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

ADMINISTRATION, ORAL; HUMANS; INJECTIONS, INTRAVENOUS; MODELS, BIOLOGICAL; PHARMACOKINETICS;

EID: 0031767963     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Chan KKH and Gibaldi M (1990) Effects of first-pass metabolism on metabolite mean residence time determination after oral administration of parent drug. Pharm Res 7:59-63.
2. Hasselström J and Säwe J (1993) Morphine pharmacokinetics and metabolism in humans: enterohepatic cycling and relative contribution of metabolites to active opioid concentrations. Clin Pharmacokinet 24:344-354.
3. Karol MD and Goodrich S (1988) Metabolite formation pharmacokinetics: rate and extent of metabolite formation determined by deconvolution. Pharm Res 5:347-351.
4. Lötsch J, Weiss M, Kobal G and Geisslinger G (1998) Pharmacokinetics of morphine-6-glucuronide and its formation from morphine following i.v.-administration. Clin Pharmacol Ther, in press.
5. Nigrovic V and Banoub M (1992) Pharmacokinetic modelling of a parent drug and its metabolite atracurium and laudanosine. Clin Pharmacokinet 22:396-408.
6. Purves RD (1995) Accuracy of numerical inversion of Laplace transforms for pharmacokinetic parameter estimation. J Pharm Sci 84:71-74.
7. Wagner JG (1975) Fundamentals of Clinical Pharmacology. Drug Intelligence Publications, Hamilton, IL.
8. Weiss M (1988) A general model of metabolite kinetics following intravenous and oral administration of the parent drug. Biopharm & Drug Dispos 9:159-176.
9. Weiss M (1990) Use of metabolite AUC data in bioavailability studies to discriminate between absorption and first-pass extraction. Clin Pharmacokinet 18:419-422.
10. Weiss M (1996) A novel extravascular input function for the assessment of drug absorption in bioavailability studies. Pharm Res 13:1547-1553.
11. Weiss M and Förster W (1979) Pharmacokinetic model based on circulatory transport. Eur J Clin Pharmacol 16:287-293.